"Welcome to Organon Canada, where health matters.

Organon is a renowned global biopharmaceutical company committed to improving the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of our core therapeutic fields: fertility, gynecology and selected areas of anesthesia. In addition, we have extensive experience in neuroscience, and we conduct research in
immunology and oncology. Our products are distributed in over 100 countries, of which more than 50 have an Organon subsidiary.

Ever since our foundation in 1923 in The Netherlands, we have grown into a leading research-based and market-driven company. Organon relies first and foremost on its own expertise in research and development to produce breakthrough medicines, though we have always been open to strategic alliances. We currently have a strong and deep pipeline that is key to the company’s future, with exciting late-stage compounds being developed for each of the core therapeutic areas: gynecology (the contraceptive NOMAC/E2 and Org 50081 for hot flashes), fertility (Org 36286), anesthesia (sugammadex) and neuroscience (asenapine and Org 50081 for insomnia – second indication). In July of last year, we received FDA approval for Implanon® (contraceptive) for entry into the US market.

Organon's business has been built by people and we regard our employees as our most valuable resource. We encourage people to take an active role in exploring the boundaries of medical and pharmaceutical research, in the hope that generations to come will enjoy a healthier and more secure existence. 

We would like to invite you to discover more about Organon - our products and our people - by surfing our site and discovering together with us why health matters."